TGA approves adrenaline nasal spray

New anaphylaxis product hailed as “the biggest change... in over two decades”  CSL Seqirus’s adrenaline (epinephine) nasal spray, neffy, has been approved for use in Australia by the Therapeutic Goods Administration (TGA).   Under the TGA approval, neffy can be used to treat anaphylaxis in adults and children aged four years and older, weighing 15kg or more.   The product features the same deliver device used in opioid